FOXG1 dysregulation is a frequent event in medulloblastoma
- 357 Downloads
Medulloblastomas represent 20% of malignant brain tumors of childhood. Although, they show multiple, non-random genomic alterations, no common, early genetic event involving all histologic types of medulloblastomas have been described. Nineteen medulloblastomas were analyzed using chromosomal comparative genomic hybridization (cCGH). Nine tumors with the most frequent number of genetic changes were further analyzed using bacterial artificial chromosome array CGH (aCGH). With aCGH, the frequency of gains and losses were higher than with cCGH. Chromosome 2p gains spanning 2p11–2p25 including N-myc locus, 2p24.1 were detected in 5/9 (55%) tumors while 14q12 gains were detected in 6/9 (67%) tumors. The 14q12 locus overlapped with the FOXGI gene locus. Quantitative real time PCR showed a 2–7-fold copy gain for FOXG1 in all the nine tumors. Protein expression was demonstrated by immunohistochemistry in all histologic types. The expression of FOXG1 and p21cip1 showed an inverse relationship. FOXG1 copy gain (>2 to 21 folds) was seen in 93% (55/59) of a validating set of tumors and showed a positive correlation with protein expression (Spearman’s rank order correlation coefficient = 0.276; P = 0.038) representing the first report of FOXG1 dysregulation in medulloblastoma. Modulation of FOXG1 expression in DAOY cell line using siRNA showed a modest decrease in proliferation with a 2-fold upregulation of p21cip1. Current reports indicate that FOXG1 represses TGF-β induced expression of p21cip1 and cytostasis, and forms a transcriptional repressor complex with Notch signaling induced hes1. Our findings are consistent with a role for FOXG1 in the inhibition of TGF-β induced cytostasis in medulloblastoma.
KeywordsArray comparative genomic hybridization FOXG1 medulloblastoma p21cip1 Pediatric brain tumors Primitive neuroectodermal tumor TGF-β signaling
The supports of the Oklahoma Center for the Advancement of Science and Technology, the Moran Foundation and an equipment grant from the Presbyterian Health Foundation (AMA) are acknowledged.
- 1.Giangaspero F, Bigner SH, Kleihues P, Pietsch T, Trojanowski JQ (2000) Medulloblastoma. In: Kleihues P, Cavenee WK (eds) Pathology & genetics: tumours of the nervous system. Publisher, IARC, LyonGoogle Scholar
- 10.Aldosari N, Bigner SH, Burger PC et al (2002) MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children’s Oncology Group. Arch Pathol Lab Med 26:540–544Google Scholar
- 15.Tong C, Hui A, Yin XL et al (2004) Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J Neurosurg Spine 100:187–193Google Scholar
- 27.Draghici S (2003) Data pre-processing and normalization; In: Draghici S (eds) Data analysis tools for microarrays, Publisher, Chapman Hall/CRC, pp 309–340Google Scholar
- 31.Ellison DW, Onilude OE, Lindsey JC et al (2005) United Kingdom Children’s Cancer Study Group Brain Tumour Committee: beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children’s Cancer Study Group Brain Tumour Committee. J Clin Oncol 23:7951–7957PubMedCrossRefGoogle Scholar
- 43.Rao G, Pedone CA, Del Valle L et al (2004) Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice Oncogene 23:6156–6162Google Scholar
- 45.Hallahan AR, Pritchard JI, Hansen S et al (2004) The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas Cancer Res 64:7794–7800Google Scholar